Winn-Dixie has launched a prescription savings program offering deep discounts on more than 400 generic drugs and various levels of savings on brand-name medications and other generics. The Rx discount program runs through the Winn-Dixie Reward Card.
The National Association of Chain Drug Stores and the National Community Pharmacists Association provided comment to a Senate caucus on the pharmacy sector’s engagement in the prevention of prescription drug abuse.
To help reduce vehicle air pollution, Duane Reade is asking to New Yorkers which of its drug stores should be served solely by electric trucks. The Manhattan-based drug chain, part of Walgreen Co.
Jeffrey Farber, vice chairman at Lannett Co., has been named chairman, succeeding Ronald West. The generic drug maker said Monday that Farber takes over the chairman’s post effective immediately.
Karma Culture LLC has made its Karma Wellness Water available at drug store, supermarket and convenience store chains nationwide.
The Pharmacy Technician Certification Board (PTCB) has launched the Educator Program, which provides pharmacy technician instructors and trainers with a range of resources.
Tom O’Grady has joined pharmacy alliance RxAlly as general counsel and executive vice president of corporate development. RxAlly said Monday that O’Grady, previously with the law firm McGuireWoods LLP, brings more than 30 years of corporate and transactional law experience to the company.
Shoppers can now navigate the aisles to find what they want at Walgreens drug stores with the help of a smartphone application from aisle411, a mobile retail navigation service. The Palo Alto, Calif.
Par Pharmaceutical Cos. has agreed to be acquired by private equity firm TPG in a deal valued at $1.9 billion. The generic drug and specialty pharmaceutical company said Monday that under the agreement, Par can solicit proposals from other parties until Aug. 24, and its board plans to do so. If
Sanofi Pasteur has begun shipping the first lots of Fluzone vaccine to U.S. health care providers with the Food and Drug Administration’s licensing of the 2012-13 formulation.
GlaxoSmithKline plans to acquire Human Genome Sciences (HGS) in a cash deal of about $3 billion. GSK said Monday that the purchase of HGS will give the company full ownership of the medications Benlysta (lupus), albiglutide (type 2 diabetes) and darapladib (coronary heart disease).
Next month, The Apothecary Shops is changing its name and brand to Avella Specialty Pharmacy. The specialty pharmacy chain said Monday that it will officially switch to the Avella banner at all locations and in all business operations on Aug. 1.
At its Retail Business Conference (RBC) here, Cardinal Health Inc. introduced "Independent Pharmacy Best Practices 2012: Ideas as Original As You Are," a special publication that showcases 16 community pharmacy programs that improve patient care and drive business results.
New research by CVS Caremark Corp. and Truven Health Analytics find that employees who stick to their medication regimens are less likely to miss work.
Par Formulations Private Ltd., a subsidary of Par Pharmaceutical Cos., has received its first Abbreviated New Drug Application (ANDA) approval from the Food and Drug Administration. The company said Friday that Par Formulations, formerly Edict Pharmaceuticals Private Ltd.
Watson Pharmaceuticals Inc. is set to release Next Choice ONE DOSE (levonorgestrel 1.5 mg), an emergency contraceptive pill. The company said Friday that its Watson Laboratories Inc.
